TGFB1 and glioblastoma: Surprisingly, tumorspheres derived from TMZ-treated GBM cells released higher amounts of TGF-β1 and IL-10 and were featured by a higher percentage of CD206-positive cells, supporting a macrophage polarization towards the M2 phenotype and, thus, an immunosuppressive and pro-tumor microenvironment.